Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in combination with adjunctive drugs in fixed or unfixed combinations, will be switched from their current therapy to travoprost/timolol fixed combination and either Azopt or...
Date First Received: September 27, 2006
Last Updated: April 21, 2008
Verified by: Alcon Research, April 2008
Clinical Trial Phase: Phase 4 | Start Date: September 2006
Overall Status: Completed
Estimated Enrollment: 195
Brief Summary
Official Title: “IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy”
Condition Keyword(s):
Intervention(s):
Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in combination with adjunctive drugs in fixed or unfixed combinations, will be switched from their current therapy to travoprost/timolol fixed combination and either Azopt or placebo
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Study Primary Completion Date: August 2007
Intervention(s) in this Clinical Trial
- Drug: Azopt
Outcome Measures for this Clinical Trial
Primary Measures
- IOP lowering
Secondary Measures
- safety
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Glaucoma
Exclusion Criteria:
- Under 18
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Mark Jasek Study Director Alcon Research
Additional Information
Information obtained from ClinicalTrials.gov on October 10, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00382226
Study ID Number: CM-05-10
ClinicalTrials.gov Identifier: NCT00382226
Health Authority: Australia: Ministry of Health
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
